[18F] Fluoromisonidazole PET in rectal cancer
<p>Background: There is an increasing interest in developing predictive biomarkers of tissue hypoxia using functional imaging for personalised radiotherapy in patients with rectal cancer that are considered for neoadjuvant chemoradiotherapy (CRT). The study explores [18F]fluoromisonidazole ([1...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
BioMed Central
2017
|